NCT00032942View on ClinicalTrials.gov

Lofexidine for Opiate Withdrawal - 1

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

October 31, 2004

Conditions
Opioid-Related Disorders
Interventions
DRUG

Lofexidine

Trial Locations (3)

10023

Columbia University, New York

19104

Philadelphia Veterans Medical Center, Philadelphia

90095

UCLA Medical Center, Los Angeles

Sponsors
All Listed Sponsors
collaborator

Britannia Pharmaceuticals Ltd.

INDUSTRY

lead

National Institute on Drug Abuse (NIDA)

NIH